| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |